Study name :
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus two nucleotide reverse transcriptase inhibitors (N(t)RTI) in antiretroviral-naïve HIV-infected individuals over 96 weeks)
Research network (Code) : ENCORE 1
network: ACTG
Principle investigator : Professor Khuanchai Supparatpinyo, MD
Co-PI : Dr. Patcharaphan Sugandhavesa
Collaborators
The National Centre in HIV Epidemiology and Clinical Research: NCHECR
